FOXD3 and glioblastoma: The findings revealed that in the ROC prognostic analysis of 1-year survival of GBM and LGG patients by FOXD3-AS1, AUC = 0.744, AUC = 0.772 for 3-year, and AUC = 0.769 for 5-year (Figure 7D).